In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging

Stefan Eser, Marlena Messer, Philipp Eser, Alexander Von Werder, Barbara Seidler, Monther Bajbouj, Roger Vogelmann, Alexander Meining, Johannes Von Burstin, Hana Algül, Philipp Pagel, Angelika E. Schnieke, Irene Esposito, Roland M. Schmid, Günter Schneider, Dieter Saur

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with poor patient outcome often resulting from late diagnosis in advanced stages. To date methods to diagnose early-stage PDAC are limited and in vivo detection of pancreatic intraepithelial neoplasia (PanIN), a preinvasive precursor of PDAC, is impossible. Using a cathepsin-activatable near-infrared probe in combination with flexible confocalfluorescence lasermicroscopy (CFL) in a genetically defined mouse model of PDAC we were able to detect and grade murine PanIN lesions in real time in vivo. Our diagnostic approach is highly sensitive and specific and proved superior to clinically established fluorescein-enhanced imaging. Translation of this endoscopic technique into the clinic should tremendously improve detection of pancreatic neoplasia, thus reforming management of patients at risk for PDAC.

Original languageEnglish
Pages (from-to)9945-9950
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number24
DOIs
StatePublished - 14 Jun 2011

Keywords

  • Carcinoma in situ
  • Cathepsin
  • Early detection
  • Genetically engineered mouse model
  • Molecular in vivo imaging

Fingerprint

Dive into the research topics of 'In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging'. Together they form a unique fingerprint.

Cite this